KP
Kiora Pharma
KPRX·NASDAQSalt Lake City UTFounded 20145 employees
Micro CapbiotechPublicOphthalmology
Platform: KIO-301 RP
Market Cap
$0.005B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (KPRX)
Loading KPRX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sovaosocimab | KPR-3683 | Phase 1 | 2 | PRMT5 | MCLCKD | ||
| Ribotinib | KPR-3556 | Phase 1 | 1 | SGLT2 | Fabry |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)